|
|
||||||||

* Division of Infectious Diseases, Department of Medicine, and
Department of Microbiology, University of Alabama, Birmingham, AL 35294
Acquired immunity to murine Chlamydia trachomatis genital tract reinfection has long been assumed to be solely dependent on cell-mediated immunity. However, in this study, we identify a previously unrecognized protective role for Ab. Immunity develops in Ab-deficient mice following the resolution of primary chlamydial genital infection. Subsequent depletion of CD4+ T cells, but not CD8+ T cells, in those immune Ab-deficient mice before secondary infectious challenge, resulted in an infection that did not resolve. Passive immunization with immune (convalescent) serum conferred a marked level of protective immunity to reinfection, which was characterized by a striking decrease in bacterial shedding, from >100,000 inclusion forming units to fewer than 10 inclusion forming units, and a shortened duration of infection. Furthermore, mAbs to the chlamydial major outer membrane protein and LPS conferred significant levels of immunity to reinfection and reduced chlamydial shedding by >100-fold. Anti-heat shock protein 60 mAb had no protective effect. In contrast to the marked protective efficacy of immune serum on reinfection, the course of primary infection was essentially unaltered by the passive transfer of immune serum. Our results convincingly demonstrate that Abs contribute importantly to immunity to chlamydial genital tract reinfection, and that Ab-mediated protection is highly dependent on CD4+ T cell-mediated adaptive changes that occur in the local genital tract tissues during primary infection. These results impact our understanding of immunity to chlamydial genital infection and may provide important insight into vaccine development.
Related articles in The JI:
This article has been cited by other articles:
![]() |
Z. Li, D. Chen, Y. Zhong, S. Wang, and G. Zhong The Chlamydial Plasmid-Encoded Protein pgp3 Is Secreted into the Cytosol of Chlamydia-Infected Cells Infect. Immun., August 1, 2008; 76(8): 3415 - 3428. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Karunakaran, J. Rey-Ladino, N. Stoynov, K. Berg, C. Shen, X. Jiang, B. R. Gabel, H. Yu, L. J. Foster, and R. C. Brunham Immunoproteomic Discovery of Novel T Cell Antigens from the Obligate Intracellular Pathogen Chlamydia J. Immunol., February 15, 2008; 180(4): 2459 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cheng, P. Shivshankar, Z. Li, L. Chen, I-T. Yeh, and G. Zhong Caspase-1 Contributes to Chlamydia trachomatis-Induced Upper Urogenital Tract Inflammatory Pathologies without Affecting the Course of Infection Infect. Immun., February 1, 2008; 76(2): 515 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Marks, M. Verolin, A. Stensson, and N. Lycke Differential CD28 and Inducible Costimulatory Molecule Signaling Requirements for Protective CD4+ T-Cell-Mediated Immunity against Genital Tract Chlamydia trachomatis Infection Infect. Immun., September 1, 2007; 75(9): 4638 - 4647. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, D. Chen, J. Sharma, W. Cheng, Y. Zhong, K. Liu, J. Jensen, R. Shain, B. Arulanandam, and G. Zhong The Hypothetical Protein CT813 Is Localized in the Chlamydia trachomatis Inclusion Membrane and Is Immunogenic in Women Urogenitally Infected with C. trachomatis. Infect. Immun., August 1, 2006; 74(8): 4826 - 4840. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Pammit, E. K. Raulie, C. M. Lauriano, K. E. Klose, and B. P. Arulanandam Intranasal Vaccination with a Defined Attenuated Francisella novicida Strain Induces Gamma Interferon-Dependent Antibody-Mediated Protection against Tularemia Infect. Immun., April 1, 2006; 74(4): 2063 - 2071. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Crane, J. H. Carlson, E. R. Fischer, P. Bavoil, R.-c. Hsia, C. Tan, C.-c. Kuo, and H. D. Caldwell From the Cover: Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen PNAS, February 7, 2006; 103(6): 1894 - 1899. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |